Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion.
Wenbei PengLinlin YeQianqian XueXiaoshan WeiZihao WangXuan XiangSiyu ZhangPei ZhangHaolei WangQiong ZhouPublished in: Cells (2023)
This study identifies circCRIM1 as a new tumor suppressor that inhibits tumor immune evasion through a competitive combination with IGF2BP1 to destabilize HLA-F mRNA.